Literature DB >> 31121577

Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.

Ryosuke Tashiro1,2, Miki Fujimura3, Masayuki Kameyama1, Shunji Mugikura4, Hidenori Endo2, Yohei Takeuchi1, Yasutake Tomata5, Kuniyasu Niizuma2, Teiji Tominaga2.   

Abstract

OBJECTIVE: Superficial temporal artery-middle cerebral artery (STA-MCA) anastomosis is the standard surgical management for adult moyamoya disease (MMD) patients, but local cerebral hyperperfusion (CHP) and cerebral ischemia are potential complications of this procedure. Recent hemodynamic analysis of the acute stage after revascularization surgery for MMD revealed a more complex and unique pathophysiological condition, the so-called "watershed shift (WS) phenomenon," which is defined as a paradoxical decrease in the cerebral blood flow (CBF) at the adjacent cortex near the site of local CHP. The objective of this study was to clarify the exact incidence, clinical presentation, and risk factors of the WS phenomenon after direct revascularization surgery for adult MMD. PATIENTS AND METHODS: Among 74 patients with MMD undergoing STA-MCA anastomosis for 78 affected hemispheres, 60 adult patients comprising 64 hemispheres underwent serial quantitative CBF analysis by N-isopropyl-p-[123I] iodoamphetamine single-photon emission computed tomography after revascularization surgery. The local CBF was quantitatively measured at the site of anastomosis and the adjacent cortex before surgery, as well as on 1 and 7 days after surgery. Then, we investigated the incidence, clinical presentation, and risk factors of the WS phenomenon.
RESULTS: The WS phenomenon was evident in 7 patients (7/64 hemispheres; 10.9%) after STA-MCA anastomosis for adult MMD. None of the patients developed neurological deterioration due to the WS phenomenon, but 1 patient developed reversible ischemic change on diffusion-weighted imaging at the site of the WS phenomenon. Multivariate analysis revealed that a lower preoperative CBF value was significantly associated with the occurrence of the WS phenomenon (20.3 ± 7.70 mL/100 g/min in WS-positive group vs. 31.7 ± 8.81 mL/100 g/min in WS-negative group, p= 1.1 × 10-2).
CONCLUSIONS: The incidence of the WS phenomenon was as high as 10.9% after STA-MCA anastomosis for adult MMD. The clinical outcome of the WS phenomenon is generally favorable, but there is a potential risk for perioperative cerebral infarction. Thus, we recommend routine CBF measurement in the acute stage after revascularization surgery for adult MMD to avoid surgical complications, such as local CHP and cerebral ischemia, caused by the WS phenomenon. Concomitant detection of the WS phenomenon with local CHP is clinically important because blood pressure reduction to counteract local CHP may have to be avoided in the presence of the WS phenomenon.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Cerebral blood flow; Focal cerebral hyperperfusion; Moyamoya disease; Superficial temporal artery-middle cerebral artery anastomosis; Watershed shift

Mesh:

Year:  2019        PMID: 31121577     DOI: 10.1159/000500802

Source DB:  PubMed          Journal:  Cerebrovasc Dis        ISSN: 1015-9770            Impact factor:   2.762


  9 in total

1.  The Recipient Vessel Hemodynamic Features Affect the Occurrence of Cerebral Edema in Moyamoya Disease After Surgical Revascularization: A Single-Center Retrospective Study.

Authors:  Liang Xu; Yin Li; Yun Tong; Jun-Wen Hu; Xu-Chao He; Xiong-Jie Fu; Guo-Yang Zhou; Yang Cao; Xiao-Bo Yu; Hang Zhou; Chao-Ran Xu; Lin Wang
Journal:  Front Neurol       Date:  2022-05-16       Impact factor: 4.086

2.  Pre-operative higher hematocrit and lower total protein levels are independent risk factors for cerebral hyperperfusion syndrome after superficial temporal artery-middle cerebral artery anastomosis with pial synangiosis in adult moyamoya disease patients-case-control study.

Authors:  Masahito Katsuki; Miki Fujimura; Ryosuke Tashiro; Yasutake Tomata; Taketo Nishizawa; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2020-09-24       Impact factor: 3.042

3.  2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society.

Authors:  Miki Fujimura; Teiji Tominaga; Satoshi Kuroda; Jun C Takahashi; Hidenori Endo; Kuniaki Ogasawara; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2022-02-22       Impact factor: 2.036

4.  Paradoxical association of symptomatic cerebral edema with local hypoperfusion caused by the 'watershed shift' after revascularization surgery for adult moyamoya disease: a case report.

Authors:  Jin Yu; Miao Hu; Lei Yi; Keyao Zhou; Jianjian Zhang; Jincao Chen
Journal:  Ther Adv Neurol Disord       Date:  2019-09-25       Impact factor: 6.570

5.  Cerebral Hyperperfusion and Concomitant Reversible Lesion at the Splenium after Direct Revascularization Surgery for Adult Moyamoya Disease: Possible Involvement of MERS and Watershed Shift Phenomenon.

Authors:  Ryosuke Tashiro; Miki Fujimura; Taketo Nishizawa; Atsushi Saito; Teiji Tominaga
Journal:  NMC Case Rep J       Date:  2021-08-06

6.  Intraoperative Early Venous Filling Phenomenon as an Intrinsic Sign of the Local Hemodynamic Change after Revascularization Surgery in a Patient with Adult Moyamoya Disease: Implications of a Potential Arteriovenous Shunt.

Authors:  Kikutaro Tokairin; Taku Sugiyama; Masaki Ito; Miki Fujimura
Journal:  NMC Case Rep J       Date:  2021-11-02

Review 7.  Severe cerebral edema induced by watershed shift after bypass in a patient with chronic steno-occlusive disease: a case report and short literature review.

Authors:  Yin Li; Yu-Yu Wei; Yang Cao; Xiao-Yang Lu; Yuan Yao; Lin Wang
Journal:  BMC Neurol       Date:  2020-09-05       Impact factor: 2.474

8.  Evaluation of Hemodynamic Change by Indocyanine Green-FLOW 800 Videoangiography Mapping: Prediction of Hyperperfusion Syndrome in Patients with Moyamoya Disease.

Authors:  Xin Zhang; Wei Ni; Rui Feng; Yanjiang Li; Yu Lei; Ding Xia; Peng Gao; Shaoxuan Yang; Yuxiang Gu
Journal:  Oxid Med Cell Longev       Date:  2020-08-11       Impact factor: 6.543

Review 9.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.